118 related articles for article (PubMed ID: 20554170)
1. Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study.
Cofán M; Escurriol V; García-Otín AL; Moreno-Iribas C; Larrañaga N; Sánchez MJ; Tormo MJ; Redondo ML; González CA; Corella D; Pocoví M; Civeira F; Ros E
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):651-7. PubMed ID: 20554170
[TBL] [Abstract][Full Text] [Related]
2. Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study.
Assmann G; Cullen P; Kannenberg F; Schulte H
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):208-14. PubMed ID: 17446798
[TBL] [Abstract][Full Text] [Related]
3. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Ooi EM; Ng TW; Chan DC; Watts GF
Diabetes Res Clin Pract; 2009 Sep; 85(3):310-6. PubMed ID: 19573945
[TBL] [Abstract][Full Text] [Related]
4. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
5. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
6. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome.
Hernández-Mijares A; Bañuls C; Jover A; Solá E; Bellod L; Martínez-Triguero ML; Lagarda MJ; Víctor VM; Rocha M
Clin Nutr; 2011 Oct; 30(5):604-9. PubMed ID: 21489663
[TBL] [Abstract][Full Text] [Related]
7. Non-cholesterol sterols in different forms of primary hyperlipemias.
Lupattelli G; Pirro M; Siepi D; Mannarino MR; Roscini AR; Vaudo G; Pasqualini L; Schillaci G; Mannarino E
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):231-6. PubMed ID: 20708389
[TBL] [Abstract][Full Text] [Related]
8. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men.
Strandberg TE; Gylling H; Tilvis RS; Miettinen TA
Atherosclerosis; 2010 May; 210(1):282-7. PubMed ID: 19962145
[TBL] [Abstract][Full Text] [Related]
9. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
Miettinen TA; Hallikainen M; Raitakari OT; Viikari J; Gylling H
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
11. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
13. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
[TBL] [Abstract][Full Text] [Related]
14. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
15. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
16. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
[TBL] [Abstract][Full Text] [Related]
17. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.
Esteghamati A; Noshad S; Khalilzadeh O; Morteza A; Nazeri A; Meysamie A; Esteghamati A; Nakhjavani M
Arch Med Res; 2011 Apr; 42(3):244-51. PubMed ID: 21722822
[TBL] [Abstract][Full Text] [Related]
18. Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome.
Lupattelli G; De Vuono S; Mannarino E
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):620-7. PubMed ID: 21855307
[TBL] [Abstract][Full Text] [Related]
19. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
Niesor EJ; Chaput E; Staempfli A; Blum D; Derks M; Kallend D
Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411
[TBL] [Abstract][Full Text] [Related]
20. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation.
Nikkilä K; Miettinen TA; Höckerstedt KV; Isoniemi H
Transpl Int; 2005 Feb; 18(2):221-5. PubMed ID: 15691276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
